聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 1 小时 13 分钟 前

New Clinical Study Shows Masimo PVI(R) Helps Clinicians Optimize Fluid Administration in Patients Under Combined General and Epidural Anesthesia

周一, 04/07/2014 - 18:08
IRVINE, CA--(Healthcare Sales & Marketing Network) - Masimo (NASDAQ: MASI) announced today a recent study in the Journal of Monitoring and Computing demonstrates that Masimo's noninvasive PVI® parameter can help clinicians optimize fluid management and...
Devices, Monitoring
Masimo, PVI parameter, Masimo SET, rainbow sensor

Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Enter Into Definitive Merger Agreement Under Which Mallinckrodt Will Acquire Questcor For Approximately $5.6 Billion, Creating A Diversified, High-Growth Specialty Pharmaceuticals Company

周一, 04/07/2014 - 13:18
Questcor Shareholders Receive $30.00 in Cash and 0.897 Mallinckrodt Shares for Each Share of Questcor Common Stock They Own Combined Company Expected to Have Significantly Increased Scale, Revenues, Profitability and Cash Flow to Deliver Sustainable Gro...
Biopharmaceuticals, Mergers & Acquisitions
Mallinckrodt, Questcor Pharmaceuticals

EndoBarrier(R) Therapy Receives Reimbursement Coverage in Israel

周一, 04/07/2014 - 13:09
LEXINGTON, Mass. & SYDNEY, Australia--(Healthcare Sales & Marketing Network)--GI Dynamics, Inc. (GID.AX) today announced that Clalit Health Services, Israel’s largest and one of the world’s largest health maintenance organization (HMO), has established a r...
Devices, Reimbursement
GI Dynamics, EndoBarrier Therapy

Deciphera Pharmaceuticals Appoints Michael D. Taylor, Ph.D., as President and Chief Executive Officer

周一, 04/07/2014 - 13:04
Company to Accelerate Kinase Inhibitor Clinical Candidates in Cancer Company to Open Corporate Offices in Boston Area LAWRENCE, Kan.--(Healthcare Sales & Marketing Network)--Deciphera Pharmaceuticals, a clinical stage biotechnology company developing...
Biopharmaceuticals, Personnel
Deciphera Pharmaceuticals

Meda and Valeant Terminates Joint Ventures

周一, 04/07/2014 - 12:57
GÖTEBORG, Sweden--(Healthcare Sales & Marketing Network)--Meda (STO:MEDAA) has reached an agreement with Valeant to terminate the companies’ joint ventures in Canada, Mexico and Australia in the second quarter of 2014. In all three countries own Meda ...
Biopharmaceuticals
Meda AB, Valeant, Flupirtine, Onsolis, Sublinox

Merck Serono Announces Initiation of Phase III START2 Study with Tecemotide in Stage III Non-Small Cell Lung Cancer

周一, 04/07/2014 - 12:52
First patient dosed in tecemotide Phase III trial; study recruiting across 250 sites in over 20 countries Related Stories START2 builds upon the data from the START* trial and explores the potential of tecemotide in patients with Stage III NSCLC who ha...
Biopharmaceuticals, Oncology
Merck Serono, START2, L-BLP25, NSCLC

Genzyme to Resubmit Lemtrada(TM) Application for FDA Review

周一, 04/07/2014 - 12:42
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Genzyme, a Sanofi company (EURONEXT:SAN and NYSE:SNY), announced today that following constructive discussions with the U.S. Food and Drug Administration (FDA) the company plans to resubmit in the s...
Biopharmaceuticals, Neurology
Genzyme, Sanofi, Lemtrada, alemtuzumab, multiple sclerosis

Via Surgical Ltd. Receives FDA Clearance to Commercialize FasTouch(TM), the First Suture-Like Mesh Fixation System for Hernia Repair

周五, 04/04/2014 - 19:37
AMIRIM, Israel, April 4, 2014 -- (Healthcare Sales & Marketing Network) -- Via Surgical Ltd., a leading developer of hernia mesh fixation technologies, today announced that it has received FDA 510(k) clearance to commercialize FasTouchTM. FasTouch fixatio...
Devices, Surgery, FDA
Via Surgical, FasTouch, hernia repair

Statement by the Board of Directors of Meda

周五, 04/04/2014 - 15:52
GÖTEBORG, Sweden--(Healthcare Sales & Marketing Network)--This statement is made by the Board of Directors (the ”Board”) of Meda AB (publ) (”Meda”)(STO:MEDAA) pursuant to the Securities Markets Act and/or the Financial Instruments Trading act. The ...
Biopharmaceuticals, Mergers & Acquisitions
Meda AB, Mylan

Integra LifeSciences Announces Camino(R) Flex Ventricular Catheter Receives FDA Clearance for Use With MRI Scans

周五, 04/04/2014 - 15:49
PLAINSBORO, N.J., April 4, 2014 -- (Healthcare Sales & Marketing Network) -- Integra LifeSciences Holdings Corporation (IART) today announced that the Camino(R) Flex Ventricular Catheter has received clearance from the United States Food and Drug Administr...
Devices, Neurosurgery, FDA
Integra LifeSciences, Camino Flex, Ventricular Catheter, ICP monitor

Escalon(R) Medical Corp. Receives FDA 510(k) Clearance for the Sonomed Escalon VuPad(TM)

周五, 04/04/2014 - 15:46
An innovation in ultrasound you can see and touch ARDMORE, Pa., April 4, 2014 -- (Healthcare Sales & Marketing Network) -- Escalon Medical Corp. (ESMC) today announced that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ne...
Devices, FDA
Escalon Medical, Sonomed Escalon VuPad, ultrasound, imaging

World's First and Only Upgradeable Spinal Cord Stimulation System Receives FDA Approval

周五, 04/04/2014 - 15:40
Protégé upgradeable neurostimulator from St. Jude Medical is the world’s smallest, longest-lasting rechargeable device to treat chronic pain SCS system is designed to be non-invasively upgraded to leverage evolving technologies as they are...
Devices, Neurology, FDA
St. Jude Medical, Protégé IPG, neuromodulation, spinal cord stimulation

GTx Announces Departure of CEO

周五, 04/04/2014 - 15:36
Dr. Mitchell Steiner steps down as CEO and Vice Chairman of the Board Marc Hanover, GTx’s President and COO, named interim CEO MEMPHIS, Tenn.--(Healthcare Sales & Marketing Network)--GTx, Inc. (GTXI) today announced that Mitchell S. Steiner, its vice...
Biopharmaceuticals, Oncology, Personnel
GTx, enobosarm

EDWARDS INTUITY Elite Valve System Receives CE Mark

周五, 04/04/2014 - 15:29
Next-Generation Technology Built on Trusted, Proven Platform Designed for Enhanced Patient Benefits IRVINE, CA--(Healthcare Sales & Marketing Network) - Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and he...
Devices, Cardiology, Regulatory
Edwards Lifesciences, INTUITY Elite valve, aortic valve, heart valve

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong